M&A Update – Oct 19
– SLN to be acquired by Merck KGaA for $20.00 cash per ADS, 130.4% premium, $1.1 billion
– ATKR / PRY deal closed
– ACVA / CPRT deal closed
– PERF shareholders approved buyout by Ms. Alice H. Chang, filed delisting notice, closing Oct 23
– SYNA / ON filed DEFM14a, vote Nov 17


